Tripterifordin
|
T649148-5mg
|
|
139122-81-9 |
5mg
|
¥ 4700.9
|
期货,请咨询 |
阿拉丁 |
Tripterifordin
|
T649148-1mg
|
|
139122-81-9 |
1mg
|
¥ 1850.9
|
期货,请咨询 |
阿拉丁 |
TMX-201
|
T649137-5mg
|
≥98% |
1149339-78-5 |
5mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
TMX-201
|
T649137-25mg
|
≥98% |
1149339-78-5 |
25mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
TMX-201
|
T649137-10mg
|
≥98% |
1149339-78-5 |
10mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
Tariquidar methanesulfonate, hydrate
|
T649128-50mg
|
≥98% |
625375-83-9 |
50mg
|
¥ 2930.9
|
期货,请咨询 |
阿拉丁 |
Tariquidar methanesulfonate, hydrate
|
T649128-10mg
|
≥98% |
625375-83-9 |
10mg
|
¥ 950.9
|
期货,请咨询 |
阿拉丁 |
Tariquidar methanesulfonate, hydrate
|
T649128-100mg
|
≥98% |
625375-83-9 |
100mg
|
¥ 4604.9
|
期货,请咨询 |
阿拉丁 |
TAK-041
|
T649099-5mg
|
≥99% |
1929519-13-0 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
TAK-041
|
T649099-25mg
|
≥99% |
1929519-13-0 |
25mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
TAK-041
|
T649099-10mg
|
≥99% |
1929519-13-0 |
10mg
|
¥ 5800.9
|
期货,请咨询 |
阿拉丁 |
TAS-103 dihydrochloride
|
T649058-5mg
|
≥98% |
174634-09-4 |
5mg
|
¥ 1100.9
|
期货,请咨询 |
阿拉丁 |
TAS-103 dihydrochloride
|
T649058-50mg
|
≥98% |
174634-09-4 |
50mg
|
¥ 5200.9
|
期货,请咨询 |
阿拉丁 |
TAS-103 dihydrochloride
|
T649058-25mg
|
≥98% |
174634-09-4 |
25mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
TAS-103 dihydrochloride
|
T649058-10mg
|
≥98% |
174634-09-4 |
10mg
|
¥ 1650.9
|
期货,请咨询 |
阿拉丁 |
TAS-103 dihydrochloride
|
T649058-100mg
|
≥98% |
174634-09-4 |
100mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
Toralizumab
|
T649057-5mg
|
|
252662-47-8 |
5mg
|
¥ 9100.9
|
期货,请咨询 |
阿拉丁 |
Toralizumab
|
T649057-1mg
|
|
252662-47-8 |
1mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
Toralizumab
|
T649057-10mg
|
|
252662-47-8 |
10mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |
TRAP-6
|
T649035-5mg
|
≥99% |
141136-83-6 |
5mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
TRAP-6
|
T649035-25mg
|
≥99% |
141136-83-6 |
25mg
|
¥ 3520.9
|
期货,请咨询 |
阿拉丁 |
TRAP-6
|
T649035-10mg
|
≥99% |
141136-83-6 |
10mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
Tedalinab
|
T649025-5mg
|
≥99% |
916591-01-0 |
5mg
|
¥ 3800.9
|
期货,请咨询 |
阿拉丁 |
Tedalinab
|
T649025-25mg
|
≥99% |
916591-01-0 |
25mg
|
¥ 11500.9
|
期货,请咨询 |
阿拉丁 |